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Abstract
Background:  Despite their distinct origins, human embryonic stem (hES) and embryonic
carcinoma (hEC) cells share a number of similarities such as surface antigen expression, growth
characteristics, the ability to either self-renew or differentiate, and control of the undifferentiated
state by the same core transcription factors. To obtain further insights into the regulation of self-
renewal, we have silenced hES/hEC cell-specific genes in NCCIT hEC cells and analysed the
downstream effects by means of microarrays.
Results: RNAi-mediated silencing of OCT4 and SOX2 induced differentiation with mesodermal
characteristics. Markers of trophoblast induction were only transiently up-regulated in the OCT4
knock-down. Independent knock-downs of NANOG produced a proliferation rather than a
differentiation phenotype, which may be due to high NANOG expression levels in the cell line
used. Published ChIP-chip data from hES cells were used to identify putative direct targets. RNAi-
mediated differentiation was accompanied by direct down-regulation of known hES/hEC cell
markers. This included all three core transcription factors in the case of the OCT4 and SOX2
knock-downs, confirming previous findings of reciprocal activation in ES cells. Furthermore, large
numbers of histone genes as well as epigenetic regulators were differentially expressed, pointing at
chromatin remodeling as an additional regulatory level in the differentiation process. Moreover,
loss of self-renewal was accompanied by the down-regulation of genes involved in FGF signaling.
FGF receptor inhibition for short and prolonged periods of time revealed that the ERK/MAPK
cascade is activated by endogenously expressed fibroblast growth factors and that FGF signaling is
cruicial for maintaining the undifferentiated state of hEC cells, like in hES cells.
Conclusion: Control of self-renewal appears to be very similar in hEC and hES cells. This is
supported by large numbers of common transcription factor targets and the requirement for
autocrine FGF signaling.
Background
Human embryonic stem cells (hESCs) are, like mouse ES
cells, derived from the inner cell mass of blastocyst-stage
embryos and capable of differentiating along the three
germ layer lineages in vivo and  in vitro [1,2]. Another
defining property of ES cells is their ablity to self-renew
under appropriate conditions, i.e. to give rise to equiva-
lent daughter cells allowing indefinite propagation in cul-
ture [3]. The undifferentiated state is maintained by the
action of transcription factors (TFs) some of which are ES
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cell-specific and common between human and mouse ES
cells [4-7]. Boyer et al. [8] have identified binding sites of
the core transcription factors OCT4, NANOG, and SOX2
within regulatory regions of most known genes by ChIP-
chip analyses using human ES cells. This landmark study
revealed that these three factors bind to large numbers of
both transcribed and inactive genes many of which are co-
occupied by at least two of these three factors. These
included the OCT4, NANOG, and SOX2 genes themselves,
thus suggesting auto and reciprocal regulation amongst
themselves, which is supported by independent findings
[9-11]. A number of target genes inactive in hES cells were
developmental regulators, thus suggesting that the core
transcription factors maintain the undifferentiated state
by directly repressing these. Another level of transcip-
tional repression has recently been revealed by genome-
wide location analyses of Polycomb complexes which
repress their target genes through epigenetic modification
of chromatin structure [12,13]. ES cell chromatin is char-
acterised by an overall decondensed structure, active his-
tone marks and a large fraction of only loosely bound
proteins, notably histones. Furthermore, chromatin
remodelling factors may actively contribute to stem cell
maintenance and early differentiation [[14], and reviewed
in [15]].
Despite these similarities between human and mouse ES
cells there are striking differences with regards to surface
marker expression, signaling pathways promoting self-
renewal [16-19], and overall growth properties. For
instance, mouse ES cells are positive for the cell surface
antigen SSEA1 but not for SSEA3 and 4. Conversely,
hESCs are negative for SSEA1 but stain positive for SSEA3
and 4 [20]. In hES cells, activation of SMAD 2/3 by TGFβ/
Activin/Nodal (TGFβ pathway) and suppression of BMP
signaling is required for the maintenance of the undiffer-
entiated state, in Serum Replacement-containing medium
[21-24]. Moreover, FGF signaling appears to fulfill a mas-
ter regulatory role in sustaining hESC self-renewal since
these cells can be propagated under chemically defined
conditions with bFGF supplementation only [25]. Fur-
thermore, unlike mESCs, human ES cells display very low
replating efficiencies with high rates of spontaneous dif-
ferentiation when seeded as individual cells [26]. Thus,
they need to be passaged as clumps of cells, which also
enhances their karyotypic stability [27].
RNA interference [28] is a powerful tool to investigate self-
renewal in ES cells [29]. Unfortunately, human ES cells are
inefficiently transfected using conventional lipofection
protocols. However, human embryonic carcinoma cells
may present an alternative model system, as recently pro-
posed [30]. These are the stem cells of teratocarcinomas, a
subset of germ cell tumors. Despite their distinct origin,
hEC cells share a number of characteristics with hES cells
such as cellular morphology, surface antigen expression,
differentiation capacity, and control of the undifferenti-
ated state by OCT4 [31-33]. In addition, the overall gene
expression profiles of hEC and hES cells appear to be very
similar [[34,35], and Additional file 1]. Moreover, most
hEC cell lines do not require special culture conditions
such as feeder layer support or the addition of extrinsic
factors. This, however, may be due to their aneuploid
nature resulting in part from an adaptation to the culture
environment. In fact, hES cells tend to acquire similar
chromosomal abnormalities as hEC cells do [34,36,37].
Moreover, the need to maintain most hEC cell lines at
high density [31] may be an indication for autocrine acti-
vation of signaling pathways sustaining self-renewal.
However, this remains to be investigated.
For these reasons, hEC cells may be a suitable model for
studying the regulation of self-renewal in pluripotent
human cells. Results obtained from such an analysis may
be extrapolated to hES cells or reveal specific differences
between the two types of cells.
Results and discussion
Silencing of gene products enriched in hEC and hES cells
Genes controling the maintenance of the undifferentiated
state in hES cells may be ES cell-specific and/or down-reg-
ulated upon differentiation. Based on these requirements
we performed whole genome expression analysis of hES
cells and compared these samples to universal reference
RNA of pooled cell lines (Additional file 1). This resulted
in the identification of > 1000 genes that are preferentially
expressed in hESCs (ratio > 3). To further filter the dataset
we used expression data of undifferentiated vs. differenti-
ated hES cells and work published by others [4,34,38-43].
We then defined a set of genes supported by a maximum
number of these datasets to be enriched in undifferenti-
ated hESCs, regardless of their putative functions. A subset
of these genes was confirmed to be also expressed in hEC
cells and selected for RNAi-mediated knock-down. We
monitored the effects of these perturbations by morpho-
logical criteria as well as measurements of OCT4,
NANOG, and SOX2  expression levels (Fig. 1A). The
majority of knock-downs did not reveal apparent mor-
phological changes and displayed normal mRNA levels of
the core transcription factors. This suggests that these
genes do not have master regulatory roles in maintaining
the undifferentiated state, while we cannot rule out insuf-
ficient silencing efficiencies as an alternative explanation
for our observations in some cases (Fig. 1A). Silencing of
OCT4 and SOX2 produced apparent morphological
changes in that cells treated with OCT4 and SOX2 esiRNA
[44] differentiated from 1–2 days post transfection.
The NANOG knock-down, somewhat surprisingly,
yielded a diminished proliferation phenotype (Fig. 1B). InBMC Developmental Biology 2007, 7:46 http://www.biomedcentral.com/1471-213X/7/46
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contrast, in human ES cells silencing of NANOG has been
shown to result in the loss of pluripotency [45,46]. To
confirm the NANOG RNAi phenotype in our hEC cells we
employed a second esiRNA pool corresponding to a dif-
ferent region of the transcript. Again, we observed a signif-
icant reduction in cellular proliferation (not shown).
Moreover, we did not observe this in any other knock-
down performed, thus suggesting that the phenotype is
specific. In contrast to the OCT4 and SOX2 RNAi samples,
cells treated with NANOG esiRNA remained OCT4 posi-
tive, as monitored by immunocytochemistry (Fig. 1C).
Western blot analysis showed that SOX2 protein levels
also remained unaffected in the NANOG knock-down. In
contrast, silencing of OCT4 also caused strong down-reg-
ulation of SOX2 and diminished NANOG to levels below
those in the NANOG knock-down itself. Likewise, silenc-
ing of SOX2 caused substantial reduction of both OCT4
and NANOG protein (Fig. 1D). With the exception of the
NANOG knock-down these data are in agreement with
the model of auto and reciprocal regulation between the
three transcription factors [8-11]. To investigate whether
the failure of NANOG silencing in reducing OCT4 and
SOX2 levels points at a bona fide biological difference
between hEC and hES cells or to a specific characteristic of
the hEC cell line used [47], we employed a different batch
of NCCIT cells (ATCC CRL-2073). Again, we observed
somewhat reduced proliferation but no differentiation
following the silencing of NANOG, regardless if using a
single esiRNA pool or a combination of esiRNAs 1 and 2
(Additional file 2A). In contrast, in lines 2102Ep and
NTERA2 OCT4 and SOX2 levels were altered and CDX2, a
marker of trophoblast induction [48], was up-regulated.
However, while 2102Ep cells completely differentiated
towards a TE-like phenotype with prominent nuclei,
Silencing of OCT4, NANOG, and SOX2 in hEC cells Figure 1
Silencing of OCT4, NANOG, and SOX2 in hEC cells. (A): Initial RNAi screen on hESC marker genes in hEC cells. esiRNA-
treated samples were evaluated on the basis of cell morphology and changes in OCT4, NANOG, and SOX2 expression levels (by 
real-time PCR). Numbers at the bottom are array-based expression ratios of hESCs vs. universal reference RNA. The values 
for GDF3 and OTX2 are from an in-house platform (our unpublished data) and [34], respectively. Knock-down efficiencies were 
between 60 and > 90% throughout (not shown). (B): RNAi phenotypes in the OCT4, NANOG, and SOX2 knock-downs. Pic-
tures were taken 2.5 days after esiRNA transfection. The morphology of unmanipulated or mock-treated cells was dependent 
on the seeding density. When plated at low density as required for esiRNA transfections the cells grew as 3D-shaped colonies 
rather than in monolayers. Bottom left: Growth curves of NANOG vs. GAPDH esiRNA-transfected cells. (C): Immunostaining 
of OCT4 protein in samples prepared as in (B). Note that the NANOG RNAi cells are OCT4 positive. (D): Western blot on 
day 3 RNAi and mock control samples using OCT4, NANOG, and SOX2 antibodies. GAPDH served as a loading control.BMC Developmental Biology 2007, 7:46 http://www.biomedcentral.com/1471-213X/7/46
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NTERA2 cells only showed partial differentiation and
modest induction of later trophoblast markers KRT7 [18]
and  HCG. Hence, there appears to be heterogeneity
between available hEC cell lines, whereas the NANOG
RNAi phenotype in hES cells may probably be best mim-
icked with the 2102Ep line [30,45,46]. However, due to
OCT4 and SOX2 levels being unchanged in the NANOG
knock-down (Fig. 1D), we reasoned that the NCCIT line
may be best suited to reveal NANOG-dependent genes on
a global scale (see below).
As a possible explanation for the failure of NCCIT cells to
differentiate following the silencing of NANOG, we con-
sidered that the NANOG protein level in the RNAi sam-
ples may still be sufficiently high to sustain self-renewal.
This may seem likely given that chromosome 12 (where
NANOG is located) is frequently amplified in hEC cells as
compared to karyotypically normal hES cells [34] and
because the NANOG knock-down was incomplete (Fig.
1D). Hence, NANOG protein levels in esiRNA-treated and
mock-transfected NCCIT cells were compared to that in
undifferentiated hES cells grown in a chemically defined
medium [25]. Indeed, it appeared that NANOG is sub-
stantially more abundant in NCCIT cells as compared to
hES cells and that the level after knock-down is still in the
range of that in self-renewing hES cells (Additional file 3).
Global expression analysis
To reveal the overall downstream effects of the individual
perturbations, we performed whole genome expression
analysis on a quantitative microarray platform [49]. Using
stringent filtering criteria revealed large numbers of differ-
entially expressed genes which are presented as supple-
mentary information (Additional file 4 A–F). The
numbers, as expected given the vast change in cellular
identity (Fig. 1B), were higher in the OCT4 and SOX2
knock-downs. There were substantial overlaps between
the sets of up- and down-regulated genes, in particular
between the OCT4 and SOX2 knock-downs (Fig. 2A).
Consequenty, a comparison between the overall tran-
scriptomes revealed that the OCT4 and SOX2 RNAi sam-
ples were highly similar to each other, while the NANOG
knock-down was more closely related to the control cells
(Fig. 2B). The non-overlapping parts regarding the OCT4
and SOX2 RNAi samples (light grey areas in Fig. 2A) arose
largely due to the arbitrary thresholds set to identify differ-
ential gene expression. For instance, most genes seem-
ingly down-regulated exclusively in the OCT4 knock-
down were also down-regulated upon silencing of SOX2,
albeit to a lesser extent (ratio > 0.67) or the changes were
statistically less significant. Hence, the OCT4 and SOX2
RNAi samples were more or less equivalent and could
therefore serve as specificity controls for one another. This
was also confirmed by real-time PCR for a subset of the
differentially expressed genes (see Additional file 5). To
address the issue of off-target effects [50] in the NANOG
knock-down we additionally analysed RNAi samples pro-
duced with an alternative esiRNA amplicon. This revealed
a remarkable similarity between the independent RNAi
samples in that essentially the same genes were identified
as being differentially expressed (Fig. 2C). An explanation
for the reduction of off-target effects using pooled siRNAs
has been proposed [51]. In conclusion, the false positive
rate of the data (Additional file 4) is low. To test whether
the expression changes measured using the microarrays
are quantitative, we additionally determined the expres-
sion ratios of several NANOG targets using real-time RT-
PCR. This revealed a strong agreement between independ-
ent knock-downs using different esiRNAs and the two
methods for transcript level quantification (Fig. 2D). This,
together with data presented in Additional file 5, suggests
that the microarray data are indeed quantitative.
Expression of lineage-specific markers
The cells obtained after silencing of OCT4 and SOX2 had
a flattened but overall undefined morphology accompa-
nied by a reduction of cellular proliferation (Fig. 1B). To
characterise the nature of the differentiated cells we inves-
tigated the expression of lineage-specific markers. Sup-
pression of OCT4 activity in hES cells results in the up-
regulation trophectodermal and primitive endoderm
markers [32,42,52]. Similarly, several, but not all, hEC cell
lines have been shown by PCR to up-regulate markers of
the trophoblast lineage following OCT4 knock-down
[32,33]. We did not detect trophoblast-specifying genes
such as CDX2 in the OCT4 RNAi samples, by means of
microarrays. To confirm this, we used real-time PCR as a
more sensitive means of quantifying changes in gene
expression, employing two different batches of NCCIT
cells as well as other hEC cell lines. In 2102Ep and, some-
what surprisingly [32], NTERA2 cells, silencing of OCT4
lead to the up-regulation of all trophoblast differentiation
markers tested (CDX2, KRT7 – data in [18], and HCG).
However, the NCCIT cells only showed a transient induc-
tion of CDX2 and KRT7 at day 2 but no significant induc-
tion of the later marker HCG at day 4 (Additional file 2A).
Hence, the NCCIT cells did not differentiate to trophob-
last following OCT4 knock-down.
Instead, from a collection of marker gene expression data,
it was evident that they have mesodermal characteristics.
For instance, we observed strong induction of regulators
such as MSX1,  HAND1, and RUNX1, morphogens
(BMP4), smooth muscle and cardiac actin, as well as mes-
oderm-specific collagens. Notably, most of these markers
were not up-regulated in the NANOG knock-down, con-
sistent with its undifferentiated phenotype. In contrast,
virtually no endodermal and ectodermal marker genes
were induced (Table 1). Since the original NCCIT cells
had been shown to be capable of extraembryonic differen-BMC Developmental Biology 2007, 7:46 http://www.biomedcentral.com/1471-213X/7/46
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tiation [47,53], the failure to continuously up-regulate
trophectodermal markers may be due to a partial loss of
developmental potential at some point in the past. Alter-
natively, it may be a cell type-specific effect. Interestingly,
there are indications that trophoblast and mesodermal
differentiation programmes may be somewhat related in
that they involve at least some shared players. For
instance, the transcription factor EOMES is expressed in
both lineages and required for their specification [54].
Also, HAND1 has been implicated in trophoblast differ-
entiation as well as in extraembryonic mesoderm and car-
diac development [55,56]. Moreover, while bone
morphogenic proteins are known inducers of mesoder-
mal gene expression in different systems including hEC
cells [31], BMP4 in particular has also been shown to pro-
mote trophoblast differentiation of hES cells [18]. We
therefore speculate that the mesoderm-like differentiation
in NCCIT cells may be a default fate aquired upon OCT4
ablation, possibly mediated by the induction of BMPs
that could otherwise be interpreted as trophoblast-induc-
ing signals (see below).
Downstream targets of OCT4, NANOG, and SOX2 in 
hECCs
Clearly, the large numbers of differentially expressed
genes following OCT4, NANOG, and SOX2 RNAi (Fig.
2A, Additional file 4) are only in part directly regulated by
these factors. To reveal which of the differentially
expressed genes may be putative direct targets we made
use of the ChIP-chip dataset by Boyer et al. [8] which is
based on hES cells. Overall, there was a substantial over-
lap between the different datasets, which, however, was
reduced when applying high-stringency filtering criteria
for differential expression to our RNAi-chip data (Addi-
tional file 4). For instance, of the 414 genes down-regu-
lated upon silencing of NANOG, 66 are direct targets in
hES cells, based on the Boyer dataset. Significantly, most
of these were also down-regulated in the OCT4 and SOX2
Expression profiling of OCT4, NANOG, and SOX2 RNAi samples Figure 2
Expression profiling of OCT4, NANOG, and SOX2 RNAi samples. (A): Overlaps of differentially expressed genes. The areas of 
the squares are proportional to the numbers of genes which they represent [77]. O = OCT4 knock-down, N = NANOG k.d., 
S = SOX2 k.d. (B): Correlation-based dendogram of RNAi samples and control. Note the high similarity between the OCT4 
and SOX2 knock-downs. r = linear correlation coefficient. (C): Scatter plots of independent NANOG knock-downs and mock 
controls. esiRNA 1 and 2 were derived from non-overlapping parts of the NANOG mRNA. The dashed line indicates the 
expression threshold based upon negative control beads. Only significantly expressed genes were considered in the correlation 
analysis. (D): Array and real-time PCR-based mRNA expression measurements of NANOG downstream targets using the two 
independent NANOG esiRNA pools. Note the high degree of concordance between the independent knock-downs and meth-
ods of mRNA quantification. Values are means of two biological replicates ± SE.BMC Developmental Biology 2007, 7:46 http://www.biomedcentral.com/1471-213X/7/46
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knock-downs, as expected, because in these samples
NANOG was diminished, as well (Fig. 1A and 1D, left part
of Fig. 2A – "ONS"). These genes are therefore likely to be
NANOG targets directly activated both in undifferentiated
hES and hEC cells. Examples include genes preferentially
expressed in hES cells [4,34,38] such as DPPA4, GDF3,
HESX1, PRDM14, TERF1, ZIC2, and ZNF206 (Table 2).
Some of these as well as genes indirectly down-regulated
in all three knock-downs (DNMT3B) were part of our ini-
tial screen (Fig. 1A). The fact that these genes were also
down-regulated in the NANOG RNAi samples, which did
not show any signs of differentiation, might explain why
their silencing did not result in a loss of the undifferenti-
ated state and, hence, they may not be absolutely required
for self-renewal. Therefore, in the context of hES and hEC
self-renewal, genes down-regulated in the OCT4 and
SOX2 but not in the NANOG knock-downs are of utmost
interest (left part of Fig. 2A – "OS-ONS"). This set com-
prises 145 genes directly regulated by either of the three
TFs. Many of these as well as indirectly affected genes are
also markers of undifferentiated ES cells. Examples
include  AASS,  DPPA3  (STELLA),  FLJ10884,  FOXO1A,
LIN28, POU5F1 (encoding OCT4) itself, SOX8, SOX13,
STAT3 [57], TDGF1, TRIM22, ZIC3, ZNF589, and, inter-
estingly, kruppel-like factor 4 (KLF4, Table 2). Klf4 has
recently been implicated in reprogramming fibroblasts to
an ES cell-like state, in conjuction with Oct4, Sox2, and c-
Myc [58]. Hence, the orthologue KLF4  may play an
important role in hEC and hES cells, as well. The mRNA
level of MYC, though expressed in hEC and hES cells, did
not change significantly in the OCT4 and SOX2 knock-
downs (data not shown). Another gene, Esrrb (estrogen-
related receptor beta), has recently been identified as a key
regulator in mouse ES cells by two independent studies
[29,59]. However, based on our array data, the expression
of the orthologue ESRRB was below detectable levels both
in hEC and hES cells.
Furthermore, the genes down-regulated in the OCT4 and
SOX2 but not in the NANOG RNAi samples comprised
between ca. 20 to 30 histones. Depending on the thresh-
olds for expression ratio and statistical significance, many
of these are direct (SOX2) targets in hES cells, according to
Boyer et al. [8] (Tables 2 and S1). In addition, we noticed
that histone acetylases (MYST2, MYST4) as well as the
SWI/SNF family member SMARCA3 were down-regulated
and histone deacetylases (HDAC5, HDAC9 – direct SOX2
target in hES cells, Table 2) were induced. Besides the tran-
scriptional control by TFs, these findings strongly suggest
modification of chromatin structure as an additional
mechanism to drive/accompany the transition from
undifferentiated towards differentiated cell identity [42].
This is in agreement with the current model of chromatin
states in ES vs. differentiated cells [15] and, maybe, with
the discovery of hyperdynamic structural chromatin pro-
tein in undifferentiated ES and EC cells [14]. We also
found the Polycomb group genes PHC1 (4-fold down)
and PHC2 (4-fold up) to be differentially expressed in the
OCT4 and SOX2 knock-downs. However, a comparison
of our RNAi-chip data to PRC1 downstream targets in
mouse ES cells [12] would go beyond the scope of this
report and be too speculative at this point.
To further categorise the differentially expressed genes,
with an emphasis on the OCT4 and SOX2 RNAi datasets,
Table 1: Array-based expression ratios of lineage-specific 
markers in the OCT4, NANOG, and SOX2 knock-downs
Lineage Ratio Ratio Ratio
/GENE OCT4 kd NANOG kd SOX2 kd
endoderm
AFP n/a n/a n/a
FGF8 n/a n/a n/a
GATA4 n/a n/a n/a
GCK n/a n/a n/a
HNF4A n/a n/a n/a
ONECUT1 n/a n/a n/a
ectoderm
FGF5 n/a n/a n/a
HOXB1 n/a n/a n/a
LHX5 2.9** 1.0 1.7*
NEUROD1 n/a n/a n/a
NOG n/a n/a n/a
OLIG2 n/a n/a n/a
OTX1 n/a n/a n/a
PAX6 n/a n/a n/a
SOX1 n/a n/a n/a
mesoderm
ACTA2 22.6** n/a 22.6**
ACTC 9.2** n/a 9.2**
BMP4 5.9** 1.1 5.3**
CD34 n/a n/a n/a
COL1A1 3.2** n/a 4.4**
COL2A1 8.4** n/a 8.0**
HAND1 9.1** 3.8** 8.1**
MSX1 4.9** n/a 4.8**
MYOD1 n/a n/a n/a
RUNX1 5.3** n/a 5.5**
T n/a n/a n/a
trophoblast
CDX2 n/a n/a n/a
CSH1 n/a n/a n/a
HCG n/a n/a n/a
KRT7 n/a n/a n/a
prim. endoderm
GATA6 1.4 n/a 1.3
With the exception of LHX5, BMP4, and HAND1, none of the genes 
was expressed at detectable levels in mock-treated hEC cell cultures. 
We did not investigate whether T was transiently up-regulated during 
cellular differentiation. For the calculation of expression ratios 
reference intensities were arbitrarily set to the level of threshold 
expression. n/a denotes insignificant expression also in the RNAi 
samples. * and ** indicate statistical significance of the expression 
changes (P < 0.05 and < 0.01, respectively).BMC Developmental Biology 2007, 7:46 http://www.biomedcentral.com/1471-213X/7/46
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Table 2: Examples of differentially expressed genes.
hEC cells hES cells
Symbol Gene Name Ratio RNAi/mock ChIP-chip data [8] Ratio
down-regulated genes OCT4 NANOG SOX2 OCT4 NANOG SOX2 hES/uni
DPPA4 developmental pluripotency associated 4 0.1 0.4 0.1 +++ 5
ERBB2 v-erb-b2 erythroblastic leukemia viral oncogene 
homolog 2
0.6 2.1 0.4 -++ 8
FEZ1 fasciculation and elongation protein zeta 1 0.1 3.2 0.1 +++ 6
FLJ10884 hypothetical protein FLJ10884 0.3 0.8 0.3 -++ 1 7
FOXO1A forkhead box O1A 0.5 1.1 0.5 +++ 9
GDF3 growth differentiation factor 3 0.0 0.4 0.0 -+-
HESX1 homeo box 1 0.2 0.2 0.2 +++ 5
H2AFX H2A histone family, member X 0.6 1.0 0.6 -++
HIST1H2BE histone 1, H2be 0.6 1.0 0.6 +++
HIST1H2BG histone 1, H2bg 0.6 0.7 0.5 -++
HIST1H2BH histone 1, H2bh 0.5 0.9 0.5 -++
HIST1H2BJ histone 1, H2bj 0.4 0.9 0.4 --+
HIST1H3D histone 1, H3d 0.4 0.8 0.4 +++
HIST1H3F histone 1, H3f 0.4 0.7 0.4 -++
HIST1H3J histone 1, H3j 0.5 0.6 0.5 +++
HIST2H2AC histone 2, H2ac 0.6 1.0 0.6 +-+
HIST2H2BE histone 2, H2be 0.5 0.7 0.5 +-+
HIST2H3C histone 2, H3c 0.2 0.6 0.2 -++
HIST2H4 histone 2, H4 0.3 0.7 0.3 +++
HIST3H2A histone 3, H2a 0.3 1.0 0.3 -++
NANOG Nanog homeobox 0.1 0.2 0.1 +++ 2 4
POU5F1 POU domain, class 5, transcription factor 1 0.0 0.7 0.0 +++ 2 4
PRDM14 PR domain containing 14 0.2 0.3 0.2 +++ 1 5
SMARCA3 SWI/SNF related [...] regulator of chromatin [...] 0.5 0.5 0.5 -++
STAT3 signal transducer and activator of transcription 3 0.6 1.5 0.6 +++
TDGF1 teratocarcinoma-derived growth factor 1 0.1 0.7 0.1 +++ 4 1
TERF1 telomeric repeat binding factor 1 0.2 0.3 0.2 -+- 1 8
TRIM22 tripartite motif-containing 22 0.3 1.3 0.3 +++ 5
ZIC2 Zic family member 2 0.4 0.5 0.4 +++ 5
ZIC3 Zic family member 3 heterotaxy 1 0.3 1.0 0.3 +++ 8
ZNF206 zinc finger protein 206 0.0 0.3 0.0 -+- 4 3
AASS aminoadipate-semialdehyde synthase 0.6 0.8 0.5 12
DNMT3B DNA-methyltransferase 3 beta 0.2 0.6 0.2 21BMC Developmental Biology 2007, 7:46 http://www.biomedcentral.com/1471-213X/7/46
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DPPA3 developmental pluripotency associated 3 (STELLA) 0.1 0.7 0.0
KLF4 Kruppel-like factor 4 0.2 0.8 0.2
LIN28 lin-28 homolog 0.6 1.0 0.7 9
MYST2 MYST histone acetyltransferase 2 0.3 0.6 0.3 4
SOX13 SRY-box 13 0.4 1.1 0.4 4
SOX8 SRY-box 8 0.2 0.9 0.2 5
THY1 Thy-1 cell surface antigen 0.2 0.3 0.1 6
UTF1 undifferentiated embryonic cell transcription factor 1 0.1 0.5 0.0 26
ZNF589 zinc finger protein 589 0.5 1.0 0.5 7
up-regulated genes
BMP7 bone morphogenetic protein 7 2.7 0.9 3.0 +++
LEFTA left-right determination, factor A 50.6 6.6 54.6 +++ 4
HAND1 heart and neural crest derivatives expressed 1 9.1 3.8 8.1 +++
HDAC9 histone deacetylase 9, transcript variant 3 2.3 1.0 2.1 --+
JUN v-jun sarcoma virus 17 oncogene homolog 7.6 2.0 9.4 -+-
KRT18 keratin 18 2.9 0.5 3.0 -+-
MEIS2 Meis1, myeloid ecotropic viral integration site 1 
homolog 2
2.5 2.1 2.8 +--
ATBF1 AT-binding transcription factor 1 2.2 2.3 2.3 +++
DLX1 distal-less homeo box 1 4.1 1.0 4.0 +++
DLX2 distal-less homeo box 2 9.3 1.3 9.1 +--
ISL1 ISL1 transcription factor, LIM/homeodomain 9.0 0.7 7.2 +++
LHX1 LIM homeobox 1 2.0 1.0 1.5 ++-
LHX2 LIM homeobox 2 5.8 0.9 6.2 +++
LHX5 LIM homeobox 5 2.9 1.0 1.7 +++
PHTF2 putative homeodomain transcription factor 2 1.7 1.3 1.8 -+-
ZFHX1B zinc finger homeobox 1b 1.8 1.8 2.2 +++
DLX3 distal-less homeo box 3 3.1 1.3 2.9
IRX3 iroquois homeobox protein 3 4.0 1.0 3.7
IRX4 iroquois homeobox protein 4 2.5 1.0 2.6 4
MSX1 msh homeo box homolog 1 4.9 1.0 4.8
MSX2 msh homeo box homolog 2 1.6 0.6 1.6
PKNOX2 PBX/knotted 1 homeobox 2 4.9 2.5 5.9
PRRX2 paired related homeobox 2 1.9 1.8 1.8
ZHX1 zinc fingers and homeoboxes 1 3.1 1.0 3.3
Ratios > 1.5 or < 0.67 are in bold. In essentially all cases, these changes were also statistically significant. hESC ChIP-chip data were taken from [8]. 
The last column (expression ratio > 3 of H9 hES cells vs. universal reference RNA) indicates enriched gene expression in hES cells. SOX2 was 
below detection on the arrays but monitored by real-time PCR (Fig. 1A). See Additional file 5 for additional confirmations.
Table 2: Examples of differentially expressed genes. (Continued)BMC Developmental Biology 2007, 7:46 http://www.biomedcentral.com/1471-213X/7/46
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we mapped these to Gene Ontology terms [60]. As can be
inferred from Table 3, the genes up-regulated after ablation
of the core TFs were preferentially involved in intracellular
signaling, differentiation, cytoskeletal organisation, apop-
tosis, Wnt pathway activation, cell cycle arrest, and cell
adhesion/generation of extracellular matrix. These are all
processes that one may predict to result from the extinc-
tion of self-renewal activity. Moreover, many induced
genes are known to be involved in the generation of mes-
odermal cell types, confirming the analysis of marker gene
expression (see above). Finally, transcription factors were
enriched in the up-regulated gene sets indicating that
these are repressed in the undifferentiated state and hence,
may be involved in triggering the differentiation process
or in maintaining the differentiated cell state. Some of
them are known to be involved in lineage specification
(Table 1). A large fraction was presented by homeobox-
containing TFs many of which appear to be directly
repressed by OCT4, NANOG, and/or SOX2 in hES cells
[8] (Table 2).
In contrast, GO terms associated with the loss of self-
renewal reflected typical ES/EC cell properties, namely
high rates of primary metabolism (> 300 genes), cell cycle,
ATP consumption, and protein biosynthesis (Table 3).
The differential expression of genes involved in chromatin
remodeling has been discussed above. However, the
down-regulation of large numbers of histone genes might
additionally be interpreted as simply reflecting the overall
reduction of cell division. On the other hand, we did not
see this tendency in the NANOG RNAi samples which
also displayed reduced proliferation rates. The NANOG
phenotype (Fig. 1B) is likely a result of a reduction in met-
abolic and cell cycle activity rather than from the induc-
tion of apoptosis, as suggested by GO and KEGG pathway
analyses (results not shown). Of interest in this context
may also be the significant down-regulation of UTF1 in
the NANOG knock-down (Table 2) since the mouse
orthologue has been implicated in ES cell proliferation
[61] and revealed to be a direct Nanog target [59].
Putative receptor-mediated signaling in hEC cells
To investigate whether there may be signaling pathways
operative in maintaining the undifferentiated state of hEC
cells, we mapped the sets of genes differentially expressed
in the OCT4 and SOX2 knock-downs to known pathways
[60]. We noticed that components of the TGFβ pathway
were preferentially up-regulated upon differentiation (P <
0.01). These included BMP1, 4, 6, and 7, GREM1, TGFB2
and 3, SMAD2 and 3, and – strikingly – LEFTA (> 50-fold
up).  NODAL  and the antagonists LEFTA  and  B  are
expressed in hES cells and rapidly down-regulated upon
differentiation [22,42]. In addition to Nodal [62], TGFβ1
and Activin A have been shown to support self-renewal of
hES cells, by activating SMAD 2/3 [21,63-66]. However,
the corresponding genes are not or only weakly expressed
in hEC cells (Additional file 6) and, moreover, we failed
to amplify the SMAD binding partner FOXH1 from hEC
cDNA (not shown). These findings argue against a contri-
Table 3: Selected Gene Ontology terms associated with genes 
differentially expressed in both the OCT4 and SOX2 knock-
downs.
Over-represented GO terms associated only with down-
regulated gene sets
Biological Process No. of genes P value
primary metabolism 318 0.000
establishment and/or maintenance of 
chromatin architecture
23 0.000
mitotic cell cycle 14 0.024
steroid biosynthesis 9 0.004
activation of MAPK activity 5 0.026
Molecular Function No. of genes P value
catalytic activity 236 0.000
ATP binding 59 0.020
aminoacyl-tRNA ligase activity 9 0.000
GABA receptor activity 3 0.200
Over-represented GO terms associated only with up-
regulated gene sets
Biological Process No. of genes P value
intracellular signaling cascade 113 0.000
cell adhesion 92 0.000
apoptosis 68 0.000
cell differentiation 61 0.000
cytoskeleton organization and biogenesis 46 0.000
skeletal development 23 0.000
muscle development 20 0.000
Wnt receptor signaling pathway 16 0.002
cell cycle arrest 13 0.001
blood vessel development 11 0.013
Molecular Function No. of genes P value
calcium ion binding 94 0.000
transcription factor activity 85 0.000
cytoskeletal protein binding 63 0.000
protein kinase activity 58 0.002
extracellular matrix structural constituent 28 0.000
P values from the DAVID [76] output are a measure for the 
enrichment of the individual GO terms in the lists of up (1458) and 
down-regulated (824) genes.BMC Developmental Biology 2007, 7:46 http://www.biomedcentral.com/1471-213X/7/46
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Autocrine FGF signaling is cruicial for hEC cell self-renewal Figure 3
Autocrine FGF signaling is cruicial for hEC cell self-renewal. (A): Expression changes of genes involved in FGF signaling. Samples 
were assayed 2 and 4 days after transfection. Transcripts of FGF19, FGF2, and FGFR1 (at 96 h) were undetectable in the OCT4 
and SOX2 RNAi samples. (B): Immunostain of OCT4 protein in NCCIT hEC cells 5 days after SU5402 treatment indicating 
loss of self-renewal. (C): Cellular morphology after 5 days of SU5402 treatment vs. DMSO controls using three different hEC 
cell lines. (D): Monitoring of OCT4, NANOG, and SOX2 expression levels by real-time PCR in samples from (C). Error bars indi-
cate technical variation (DMSO control: means between cell lines). (E): Short-term effect of SU5402 treatment on MAPK phos-
phorylation in NCCIT hEC cells. Total MAPK protein (bottom panel) served as loading control. U0126 is a specific inhibitor of 
MEK (MAPKK) which directly phosphorylates ERK (MAPK). This sample served as positive control for the assay.BMC Developmental Biology 2007, 7:46 http://www.biomedcentral.com/1471-213X/7/46
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bution of TGFβ signaling to self-renewal of NCCIT hEC
cells, in contrast to the situation in hES cells when grown
in Serum Replacement-based medium. Further investiga-
tion is required to test this hypothesis.
Nevertheless, there may also be similarities between hES
and hEC cells with regards to (autocrine) receptor-medi-
ated signaling. For instance, we noticed that 3 genes
encoding GABA receptor components were down-regu-
lated upon differentiation (Table 3). This is noteworthy
because for example, GABRB3 (4-fold down in our OCT4
and SOX2 RNAi samples) is also enriched hESCs [34,35]
and GABA as well as pipecolic acid have recently been
found to support the undifferentiated growth of these
cells [63].
Moreover, we noticed that genes encoding MAPK-activat-
ing proteins were significantly down-regulated (Table 3, P
< 0.05). Interestingly, these included fibroblast growth
factors and FGF receptors. In addition, Sprouty genes
which encode modulators of FGF/MAPK signaling
induced by FGFs themselves [67,68] were repressed as
well. In contrast, FGFRL1, encoding an FGF receptor
devoid of an intracellular tyrosine kinase domain and
therefore a putative inhibitor of FGF signaling, was
strongly induced (Fig. 3A). To test whether FGF signaling
is required for self-renewal of NCCIT cells, we cultured
these in the presence and absence of a potent inhibitor of
FGF receptors [69]. After one day of SU5402 treatment,
the cells showed a reduction in growth rates and began to
differentiate. After 5 days, the cells had essentially ceased
to proliferate and were largely differentiated as monitored
by OCT4 immunostaining (Fig. 3B). To rule out that these
observations were specific to the NCCIT cells we
employed two other hEC lines and obtained essentially
the same results (Fig. 3C). OCT4, NANOG, and SOX2 lev-
els were monitored by real-time PCR, which confirmed
the loss of the undifferentiated state in all three cell lines.
These data strongly supports the notion that FGF signaling
is a general requirement for self-renewal of hEC cells. This
is likely to happen in an autocrine manner since fetal calf
serum contained in the culture medium does not contain
FGFs or, at least, FGF2 [70]. A speculative hypothesis is
that autocrine signaling provides an explanation for the
fact that several hEC lines need to be cultured at high den-
sities to prevent their spontaneous differentiation [31].
Interestingly, autocrine FGF signaling has also been
shown to be crucial in human ES cells [71] and these also
express FGF2, 13, and 19 which are down-regulated upon
induction of differentiation [4,42]. While other pathways
may as well be FGF-dependent in hES cells, FGF2 has been
shown to activate the ERK/MAPK signaling cascade [72].
To test whether this is also the case in hEC cells, we mon-
itored MAPK phosphorylation 30 minutes after SU5402
treatment. Indeed, MAPK was active in the control cells
and its phosphorylation was abolished upon FGF receptor
inhibition, as predicted (Fig. 3E).
Conclusion
Overall, our data highlights the similarities between
human EC and ES cells and further supports the idea that
pluripotent human stem cells share a number of charac-
teristics in the context of maintaining their cellular iden-
tity. This applies for the overall downstream targets of core
transcription factors as well as for the requirement of
autocrine FGF signaling. However, differences appear to
exist with regards to the expression of TGFβ pathway
genes.
Methods
esiRNA production
esiRNA was essentially produced as described elsewhere
[73]. Briefly, T7-linked products from RT-PCRs on hEC
cell cDNA were used as input for in vitro transcription reac-
tions (Ambion). After annealing of the two RNA strands,
long dsRNA was digested with in-house generated RNase
III enzyme and purified to yield pools of siRNAs with an
average size of 20–30 bp. 500–650 bp amplicons for the
initial RT-PCRs were selected from repeat-masked cDNA
regions following published guidelines to avoid theoreti-
cal cross-silencing [73]. Primer sequences are given in
Additional file 7.
Cell culture
hEC cells were grown in high-glucose DMEM supple-
mented with 10% FCS (Biochrom, Berlin/Germany), 2
mM glutamine, and penicillin/streptomycin on conven-
tional tissue culture plastic surfaces. Different lines were
compared with regards to their growth properties. We ulti-
mately chose medium-passage NCCIT cells (a kind gift by
Dr Leendert Looijenga) for our studies because this line
showed the lowest rates of spontaneous differentiation
when plated at low density (see Additional file 2C), as it
is required for high-efficiency siRNA transfections. Knock-
down efficiencies were optimised using esiRNA against
GAPDH and lipofection reagents from different manufac-
turers. We then routinely transfected hECCs by seeding
them at 20,000 cells/cm2 along with esiRNA/Hyperfect
(Qiagen) complexes (100 ng esiRNA/2 μl Hyperfect per
cm2) in multiwell plates, following the "fast-forward" pro-
tocol by Qiagen. Treatment with either transfection rea-
gent alone or Hyperfect plus irrelevant esiRNA did not
significantly alter cell survival and growth rates. Silencing
efficiencies with the GAPDH model esiRNA were ca. 90%
under the optimised conditions. In experiments presented
as supplementary data (Additional file 2), low-passage
NCCIT cells directly obtained from ATCC (CRL-2073)
were used in addition to the medium-passage NCCIT cells
employed throughout this study. Proliferation curvesBMC Developmental Biology 2007, 7:46 http://www.biomedcentral.com/1471-213X/7/46
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were recorded by counting numbers of cells in GAPDH
and NANOG esiRNA-transfected cultures by means of a
hematocytometer. Cell numbers were normalised at the
12 h timepoint to account for slight variations in plating
efficiencies. SU5402 (Calbiochem, 30 μM) was applied
continuously to lines NCCIT, 2102Ep, and NTERA2
which were seeded at titres high enough to otherwise pre-
vent significant spontaneous differentiation. DMSO-
treated cultures served as controls. For short-term effects
of SU5402 (30 μM) and U0126 (Promega, 20 μM) on
MAPK phosphorylation semiconfluent NCCIT cultures
were treated with these inhibitors and DMSO (as control)
for 30 minutes. Representative morphology was recorded
at 50-fold total magnification using an Olympus CK2
phase contrast microscope. RNA was isolated using Qia-
gen RNeasy kits with on-column DNase I digestion. Pro-
tein was extracted with an NP-40 and Benzonase-
containing buffer.
H1 and H9 hES cells [1] were purchased from the WiCell
Research Institute (Madison, Wisconsin), expanded on
feeders, and adapted to feeder-free culture in MEF-condi-
tioned medium for several passages before RNA isolation.
hESCs were maintained undifferentiated in 6-wells pre-
coated with Matrigel (BD Biosciences), using a combina-
tion of mechanical and enzymatic passaging. Composi-
tion of hES medium was as described elsewhere [74]. For
experiments presented as supplementary data (Additional
file 3), H9 hES cells were grown in a chemically defined
medium [25] to minimise potential medium-dependent
effects on NANOG protein levels.
Real-time PCR, Western blotting, immunocytochemistry
RNA was reversely transcribed using MMLV (USB) and
oligo-dT priming. Real-time RT-PCR was carried out on
Applied Biosystems 7900 instrumentation in 20 μl reac-
tions containing 10 μl of SYBR Green PCR mix (ABI),
0.375 μM of each primer, and diluted cDNA. All primer
pairs used were confirmed to approximately double the
amount of product within one cycle and to yield a single
product of the predicted size. Primer sequences are pro-
vided in Additional file 7. Relative mRNA levels were cal-
culated using the comparative Ct method (ABI instruction
manual) and presented as % of biological controls. ACTB
transcript levels were confirmed to correlate well with
total RNA amounts and therefore used for normalisation
throughout.
Western blotting was performed according to standard
procedures and using chemiluminescence detection (ECL
– Amersham). Antibodies used were Santa Cruz sc-8629
(OCT4), R&D AF1997 (NANOG), Santa Cruz sc-17320 X
(SOX2), Ambion #4300 (GAPDH), Cell Signaling Tech-
nology #9102 and #9106 (p44/42 MAPK and phospho-
MAPK, respectively), Calbiochem #401504 (HRP-linked),
as well as Amersham NA9340 and NA9310 (HRP-linked).
Following paraformaldehyde fixation and permeabilisa-
tion with Triton X-100, OCT4 immunostaining was car-
ried out employing antibodies sc-8629 (Santa Cruz) and
A21468 (Amersham). Fluorescence was visualised using a
Zeiss AxioImager Z1 microscope.
Chip hybridisations and analysis of whole-genome 
expression data
Biotin-labelled cRNA was generated using a linear ampli-
fication kit (Ambion #IL1791) using 300 ng of DNA-free,
quality-checked total RNA as input. Chip hybridisations,
washing, Cy3-streptavidin (Amersham Biosciences) stain-
ing, and scanning was performed on an Illumina BeadSta-
tion 500 platform employing reagents and following
protocols supplied by the manufacturer. cRNA samples
were hybridised as biological triplicates on Illumina
human-6 or human-8 BeadChips. Due to a 30-fold feature
redundancy quantitative expression data can be obtained
[49]. Samples to be hybridised were harvested 2 and 4
days after transfection. The OCT4 and SOX2 RNAi sam-
ples were morphologically indistinguishable in these
experiments. Analysis of the data was focussed on the day
2 samples because the data of the two timepoints were
found to be largely redundant (Fig. 3A). In addition to
information provided in Additional file 4, day 2 processed
and raw RNAi as well as hES cell expression data (vs. uni-
versal reference RNA – Stratagene #740000) have been
made accessible through GEO [75] in a MIAME-compli-
ant format (accession numbers GSE5422 and GSE5423).
All basic expression data analyses were carried out using
the manufacturer's software BeadStudio 1.0. Raw data
were background-subtracted and normalised using the
"rank invariant" algorithm, by which negative intensity
values may arise. These and values below the detection
limit were arbitrarily set to the level of threshold detection
(S = 20) in order to avoid nonsense values for expression
ratios. Differentially expressed genes were required to
change by at least 50% at P < 0.01 according to both the
t-test (assuming equal variance) and an Illumina custom
model [49]. Pathway and Gene Ontology analyses were
carried out using DAVID 2006 [76]. In both cases, we used
GenBank accession numbers represented by the corre-
sponding chip oligonucleotides as input.
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